Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

R H Ward

Showing results (121-130 of 126) with videos related to

Pageof 13
Sort By:
You have reached the last page of results.This site can display upto 126 results.
Blood|October 1, 1985
Characterization of patients with an increased susceptibility to bacterial infections and a genetic deficiency of leukocyte membrane complement receptor type 3 and the related membrane antigen LFA-1G D Ross, R A Thompson, M J Walport, et al.
American Journal of Human Genetics|September 1, 1996
Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritisB Mulcahy, F Waldron-Lynch, M F McDermott, et al.
Genetic Epidemiology|July 22, 1998
Modelling the major histocompatibility complex susceptibility to RA using the MASC methodE Génin, M C Babron, M F McDermott, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, E Mejias, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, M H Weisman, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, M H Weisman, et al.
Pageof 13

Showing results (121-130 of 126) with videos related to

Sort By:
Pageof 13
You have reached the last page of results.This site can display upto 126 results.
Blood|October 1, 1985
Characterization of patients with an increased susceptibility to bacterial infections and a genetic deficiency of leukocyte membrane complement receptor type 3 and the related membrane antigen LFA-1G D Ross, R A Thompson, M J Walport, et al.
American Journal of Human Genetics|September 1, 1996
Genetic variability in the tumor necrosis factor-lymphotoxin region influences susceptibility to rheumatoid arthritisB Mulcahy, F Waldron-Lynch, M F McDermott, et al.
Genetic Epidemiology|July 22, 1998
Modelling the major histocompatibility complex susceptibility to RA using the MASC methodE Génin, M C Babron, M F McDermott, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of psoriatic arthritis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, E Mejias, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of reactive arthritis (Reiter's syndrome). A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, M H Weisman, et al.
Arthritis and Rheumatism|December 1, 1996
Comparison of sulfasalazine and placebo in the treatment of ankylosing spondylitis. A Department of Veterans Affairs Cooperative StudyD O Clegg, D J Reda, M H Weisman, et al.
Pageof 13